Article
Efficacy and Safety of Intravitreal rAAV2-ND4 Therapy for Leber’s Hereditary Optic Neuropathy
2024-11-27
Abstract excerpt
<title>Abstract</title> <p>Background: This study aimed to assess the safety and efficacy of a rAAV2 carrying normal <italic>ND4</italic> (rAAV2-ND4) (NR082) in individuals with visual loss due to LHON carrying the m.11778G > A mutation. Additionally, it aimed to determine a safe dose of NR082 for intravitreal injection. <h4>Methods:</h4> This is a single-arm, open-label, dose-finding clinical trial. A total of...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 48b22bc0-51fe-5307-bb9b-fc204c927a21
- DOI
- 10.21203/rs.3.rs-5307802/v1
